English  |  正體中文  |  简体中文  |  Items with full text/Total items : 16984/19280 (88%)
Visitors : 8633098      Online Users : 265
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/27630


    標題: Correlation between carbapenem consumption and resistance to carbapenems among Enterobacteriaceae isolates collected from patients with intra-abdominal infections at five medical centers in Taiwan, 2006-2010
    作者: Ho, Cheng-Mao
    Ho, Mao-Wang
    Liu, Yung-Ching
    Toh, Han-Siong
    Lee, Yu-Lin
    Liu, Yuag-Meng
    Huang, Chi-Chang
    Lug, Po-Liang
    Liu, Chun-Eng
    Chen, Yen-Hsu
    Ko, Wen-Chien
    Tang, Hung-Jen
    Yu, Kwok-Woon
    Chen, Yao-Shen
    Chuang, Yin-Ching
    Wang, Jen-Hsien
    Hsueh, Po-Ren
    貢獻者: 保健營養系
    關鍵字: Enterobacteriaceae
    Intra-Abdominal Infections
    Carbapenem Resistance
    Carbapenem Consumption
    Smart
    日期: 2012-06
    上傳時間: 2014-03-21 16:15:49 (UTC+8)
    出版者: Elsevier Science Bv
    摘要: We investigated the trend in resistance to carbapenems among isolates of Enterobacteriaceae that had been collected from patients with intra-abdominal infections at five medical centers in Taiwan from 2006 to 2010 and evaluated the correlation between resistance to carbapenems and consumption of said agents as part of the Study for Monitoring Antimicrobial Resistance Trends (SMART). During the study period, the usage of ertapenem and that of total carbapenems (ertapenem, imipenem, and meropenem) increased significantly from 6.13 to 13.38 defined daily doses per 1000 patient-days for ertapenem and from 20.43 to 34.25 defined daily doses per 1000 patient-days for total carbapenems. The most common species were Escherichia coli (n = 1095), Klebsiella spp. (n = 663), and Enterobacter spp. (n = 202). The susceptibility of all isolates to ertapenem and to imipenem varied during the study period. For ertapenem, the rates of non-susceptibility ranged from 3.5% to 10.3% and those for imipenem ranged from 3.5% to 10.7%. Although the use of carbapenems increased during the study period, there was no marked increase in resistance to carbapenems. Continuous monitoring of resistance trends is necessary so that antimicrobial prescription policies can be adjusted and infection control intervention programs can be implemented. (C) 2012 Elsevier B. V. and the International Society of Chemotherapy. All rights reserved.
    Appears in Collections:[保健營養系(所) ] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML481View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback